Pfizer Interim Report January–September 2013

PFIZER REPORTS THIRD-QUARTER 2013 RESULTS

• Third-Quarter 2013 Reported Revenues of $12.6 Billion (12.9)
• Third-Quarter 2013 Adjusted Diluted EPS of $0.58 (0.50) and Reported Diluted EPS of $0.39 (0.43)
• Repurchased $3.8 Billion and $13.1 Billion of Common Stock in Third-Quarter and to Date in 2013, Respectively
• Narrowed Ranges for Certain 2013 Financial Guidance Components

2013 FINANCIAL GUIDANCE

• Adjusted Revenues $50.8 to $51.8 billion
• Reported Diluted EPS $3.05 to $3.15
• Adjusted Diluted EPS $2.15 to $2.20

For more information, click the link below
Pfizer Q3-2013

Tweet